These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 26975585)

  • 21. Intrinsic and extrinsic causes of malignancies in patients with primary immunodeficiency disorders.
    Hauck F; Voss R; Urban C; Seidel MG
    J Allergy Clin Immunol; 2018 Jan; 141(1):59-68.e4. PubMed ID: 28669558
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Immune deficiencies: diagnosis, management, some perspectives].
    Farber CM; Benoit Y; Boven K; De Baets F; Ferster A; Hoyoux C; Mascart F; Otten J; Philippet P; Van Lierde S; Van Vooren JP; Vermylen C
    Rev Med Brux; 2001 Apr; 22(2):73-82. PubMed ID: 11388026
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Endocrine complications in primary immunodeficiency diseases in Japan.
    Nozaki T; Takada H; Ishimura M; Ihara K; Imai K; Morio T; Kobayashi M; Nonoyama S; Hara T
    Clin Endocrinol (Oxf); 2012 Oct; 77(4):628-34. PubMed ID: 22432851
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Primary immunodeficiency in Japan; epidemiology, diagnosis, and pathogenesis.
    Takada H
    Pediatr Int; 2013 Dec; 55(6):671-4. PubMed ID: 24112462
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Skin manifestations in primary immunodeficient children.
    Al-Herz W; Nanda A
    Pediatr Dermatol; 2011; 28(5):494-501. PubMed ID: 21453308
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Malignancies and Lymphoproliferations in Children With Primary Immune Deficiency-A Single-center Experience.
    Aydogmus C; Turkyilmaz Ucar O; Kaplan Sarikavak S; Cipe F; Ulas S; Turan I; Naiboglu S; Yildirim I; Kalay G; Kapci N; Al S; Gokmirza Ozdemir P; Celiksoy MH
    J Pediatr Hematol Oncol; 2024 Mar; 46(2):e169-e173. PubMed ID: 38277623
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Immunodeficiency-malignancy association at autopsy in Japan.
    Yoshitomi F; Tanaka K
    Acta Pathol Jpn; 1983 Sep; 33(5):907-10. PubMed ID: 6650170
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Neutropenia and primary immunodeficiency diseases.
    Rezaei N; Moazzami K; Aghamohammadi A; Klein C
    Int Rev Immunol; 2009; 28(5):335-66. PubMed ID: 19811314
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Primary immunodeficiencies and haemato-oncology].
    Müller J; Kovács G
    Orv Hetil; 2018 Dec; 159(49):2073-2078. PubMed ID: 30525881
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Molecular diagnosis of primary immunodeficiency diseases in a developing country: Iran as an example.
    Latif AH; Tabassomi F; Abolhassani H; Hammarström L
    Expert Rev Clin Immunol; 2014 Mar; 10(3):385-96. PubMed ID: 24450304
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The evaluation of malignancies in Turkish primary immunodeficiency patients; a multicenter study.
    Cekic S; Metin A; Aytekin C; Edeer Karaca N; Baris S; Karali Y; Kiykim A; Karakoc Aydıner E; Ozen A; Aslan T; Sevinir B; Aksu G; Kutukculer N; Kilic SS
    Pediatr Allergy Immunol; 2020 Jul; 31(5):528-536. PubMed ID: 32060950
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Secondary hematopoietic malignancies in survivors of childhood cancer: an analysis of 111 cases from the Surveillance, Epidemiology, and End Result-9 registry.
    Rihani R; Bazzeh F; Faqih N; Sultan I
    Cancer; 2010 Sep; 116(18):4385-94. PubMed ID: 20549819
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Recurrent invasive pneumococcal disease in children--host factors and vaccination response.
    Ingels HA
    Dan Med J; 2015 Jul; 62(7):. PubMed ID: 26183055
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Primary immune regulatory disorders for the pediatric hematologist and oncologist: A case-based review.
    Chandrakasan S; Chandra S; Davila Saldana BJ; Torgerson TR; Buchbinder D
    Pediatr Blood Cancer; 2019 May; 66(5):e27619. PubMed ID: 30697957
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Targeted next-generation sequencing: a novel diagnostic tool for primary immunodeficiencies.
    Nijman IJ; van Montfrans JM; Hoogstraat M; Boes ML; van de Corput L; Renner ED; van Zon P; van Lieshout S; Elferink MG; van der Burg M; Vermont CL; van der Zwaag B; Janson E; Cuppen E; Ploos van Amstel JK; van Gijn ME
    J Allergy Clin Immunol; 2014 Feb; 133(2):529-34. PubMed ID: 24139496
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Family history of hematopoietic malignancy and risk of lymphoma.
    Chang ET; Smedby KE; Hjalgrim H; Porwit-MacDonald A; Roos G; Glimelius B; Adami HO
    J Natl Cancer Inst; 2005 Oct; 97(19):1466-74. PubMed ID: 16204696
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Consanguinity and primary immunodeficiencies.
    Al-Herz W; Aldhekri H; Barbouche MR; Rezaei N
    Hum Hered; 2014; 77(1-4):138-43. PubMed ID: 25060276
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Parental consanguinity and the risk of primary immunodeficiency disorders: report from the Kuwait National Primary Immunodeficiency Disorders Registry.
    Al-Herz W; Naguib KK; Notarangelo LD; Geha RS; Alwadaani A
    Int Arch Allergy Immunol; 2011; 154(1):76-80. PubMed ID: 20664281
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Thromboembolic complications in pediatric hematologic malignancies.
    Athale UH; Chan AK
    Semin Thromb Hemost; 2007 Jun; 33(4):416-26. PubMed ID: 17525899
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Primary immunodeficiency disorders in 51 cases].
    Lamia S; Aloulou H; Kamoun T; Chabchoub I; Ben Moustapha I; Barbouch R; Mongia H
    Tunis Med; 2013 Jan; 91(1):38-43. PubMed ID: 23404596
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.